🇺🇸 Magnesium Esomeprazole in United States
355 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 355
Most-reported reactions
- Acute Kidney Injury — 57 reports (16.06%)
- Hyponatraemia — 44 reports (12.39%)
- Diarrhoea — 42 reports (11.83%)
- Drug Interaction — 39 reports (10.99%)
- Nausea — 38 reports (10.7%)
- Off Label Use — 30 reports (8.45%)
- Asthenia — 27 reports (7.61%)
- Thrombocytopenia — 27 reports (7.61%)
- Vomiting — 26 reports (7.32%)
- Drug Ineffective — 25 reports (7.04%)
Other Gastroenterology approved in United States
Frequently asked questions
Is Magnesium Esomeprazole approved in United States?
Magnesium Esomeprazole does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Magnesium Esomeprazole in United States?
Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.